The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia

被引：0
|
作者：
Fistra Janrio Tandirerung
机构：
[1] University College London (UCL),The Institute of Cardiovascular Science
来源：
Current Cardiology Reports | 2022年 / 24卷
关键词：
Low-density-lipoprotein cholesterol (LDLC); Familial hypercholesterolemia; Monogenic; Polygenic hypercholesterolemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1669 / 1677
页数：8
相关论文
共 50 条
  • [1] The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
    Tandirerung, Fistra Janrio
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (11) : 1669 - 1677
  • [2] Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts, Julia
    Dharmayat, Kanika, I
    Ray, Kausik K.
    Vallejo-Vaz, Antonio J.
    CURRENT OPINION IN LIPIDOLOGY, 2020, 31 (03) : 111 - 118
  • [3] FAMILIAL HYPERCHOLESTEROLEMIA - MONOGENIC, POLYGENIC OR BOTH?
    Medeiros, Ana Margarida
    Alves, Ana Catarina
    Chora, Joana Rita
    Bourbon, Mafalda
    MEDICINE, 2022, 101 (30)
  • [4] Monogenic, polygenic, and oligogenic familial hypercholesterolemia
    Tada, Hayato
    Nohara, Atsushi
    Kawashiri, Masa-aki
    CURRENT OPINION IN LIPIDOLOGY, 2019, 30 (04) : 300 - 306
  • [5] CORONARY ARTERY CALCIUM IN PATIENTS WITH MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA VS POLYGENIC HYPERCHOLESTEROLEMIA
    Ernaga Lorea, Ander
    Martinez De Esteban, Juan Pablo
    Apellaniz-Ruiz, Maria
    Arasanz Armengol, Monica
    Garcia Torres, Javier
    Anda Apinaniz, Emma
    ATHEROSCLEROSIS, 2024, 395
  • [6] MONOGENIC FAMILIAL HYPERCHOLESTEROLEMIA, POLYGENIC HYPERCHOLESTEROLEMIA, AND THE RISK OF PREMATURE ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
    Trinder, M.
    Li, X.
    DeCastro, M. L.
    Cermakova, L.
    Sadananda, S.
    Jackson, L.
    Azizi, H.
    Mancini, G. B. J.
    Francis, G.
    Frohlich, J.
    Brunham, L.
    ATHEROSCLEROSIS, 2019, 287 : E91 - E91
  • [7] Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
    Sharifi, Mahtab
    Higginson, Elizabeth
    Bos, Sven
    Gallivan, Angela
    Harvey, Darren
    Li, Ka Wah
    Abeysekera, Amali
    Haddon, Angela
    Ashby, Helen
    Shipman, Kate E.
    Cooper, Jackie A.
    Futema, Marta
    van Lennep, Jeanine E. Roeters
    Sijbrands, Eric J. G.
    Labib, Mourad
    Nair, Devaki
    Humphries, Steve E.
    ATHEROSCLEROSIS, 2017, 263 : 405 - 411
  • [8] GENETIC TESTING OF FAMILIAL HYPERCHOLESTEROLEMIA: MONOGENIC FORM AND POLYGENIC CONTRIBUTION TO CARDIOVASCULAR RISK
    Couvert, Philippe
    Giral, Philippe
    Boelle, Pierre-Yves
    Carreau, Valerie
    Beliard, Sophie
    Lacorte, Jean-Marc
    Lesnik, Philippe
    Paillard, Francois
    Valero, Rene
    Rotthier, Annelies
    Bruckert, Eric
    Carrie, Alain
    ATHEROSCLEROSIS, 2017, 263 : E94 - E94
  • [9] Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia
    Trinder, Mark
    Li, Xuan
    DeCastro, Maria Liza
    Cermakova, Luba
    Sadananda, Singh
    Jackson, Linda M.
    Azizi, Hawmid
    Mancini, G. B. John
    Francis, Gordon A.
    Frohlich, Jiri
    Brunham, Liam R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (04) : 512 - 522
  • [10] ATHEROSCLEROSIS IN MONOGENIC FAMILIAL HYPERCHOLESTER0-OLEMIA VERSUS POLYGENIC HYPERCHOLESTEROLEMIA
    Sharifi, M.
    Gallivan, A.
    Harvey, D.
    Wah, L. Ka
    Cooper, J.
    Futema, M.
    Humphries, S. E.
    Nair, D.
    ATHEROSCLEROSIS, 2016, 252 : E36 - E37
12345